Combining the effectiveness of Sage’s innovative portfolio with 3M’s worldwide reach is a natural fit for both companies and one that we feel includes a lot of promise in addressing marketplace needs. .. 3M’s Infection Avoidance Division, Sage Products enter second agreement Sage Products and 3M’s Infection Avoidance Division have entered into an agreement which includes product sales representation of Sage Items by 3M in select international locations. The new agreement may be the second collaboration announced by the two companies lately. In December 2010, the firms announced the inclusion of 3M’s Peridex Oral Wash in Sage’s Q-Care Rx system. Effective immediately, this second agreement builds upon the original partnership and expands the reach of Sage’s leading illness prevention products into markets where they are not currently sold.There was no significant between-group difference in the primary composite cardiovascular result or in the secondary composite cardiovascular outcome . Outcomes from all sensitivity analyses were consistent with the findings in the main analyses. Other Secondary Outcomes There was no significant difference in the rate of hospitalization for heart failure, that was reported in 228 patients in the sitagliptin group and 229 in the placebo group . The composite outcome of hospitalization for heart failure or cardiovascular loss of life occurred in 538 patients in the sitagliptin group and 525 in the placebo group .